TPO and systemic lupus erythematosus: Autoantibodies against TPO have been detected in 23–39% of SLE patients [35,37]; however, as is similar to our case, their exact role in the pathogenesis of thrombocytopenia remains unknown, even though they seem to contribute to increased peripheral platelet turnover and a reduction in the effective circulating TPO.